These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38215139)

  • 1. Risk factors and prognosis for the development of acute kidney injury in patients using colistin in the intensive care unit: A retrospective cohort study.
    Deniz M; Alişik M
    Medicine (Baltimore); 2024 Jan; 103(2):e36913. PubMed ID: 38215139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity caused by colistin use in ICU: a single centre experience.
    Kilic I; Ayar Y; Ceylan İ; Kaya PK; Caliskan G
    BMC Nephrol; 2023 Oct; 24(1):302. PubMed ID: 37833622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prognosis and nephrotoxicity in patients treated with colistin in intensive care unit.
    Gunay E; Kaya S; Baysal B; Yuksel E; Arac E
    Ren Fail; 2020 Nov; 42(1):704-709. PubMed ID: 32703065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.
    Dalfino L; Puntillo F; Ondok MJ; Mosca A; Monno R; Coppolecchia S; Spada ML; Bruno F; Brienza N
    Clin Infect Dis; 2015 Dec; 61(12):1771-7. PubMed ID: 26354965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.
    Crass RL; Rutter WC; Burgess DR; Martin CA; Burgess DS
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine may reduce the risk of acute kidney injury development in critically ill patients during colistin therapy.
    Kucuk M; Heybeli C; Ozturk MC; Ergun B; Yakar MN; Gokmen AN; Comert B; Ergan B
    J Infect Chemother; 2023 Jul; 29(7):673-677. PubMed ID: 36921764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
    Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
    Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury following colistin treatment in critically-ill patients: may glucocorticoids protect?
    Heybeli C; Canaslan K; Oktan MA; Yıldız S; Arda HÜ; Çavdar C; Çelik A; Gökmen N; Cömert B
    J Chemother; 2021 Apr; 33(2):85-94. PubMed ID: 32500843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy.
    Ozel AS; Ergönül Ö; Korten V
    J Infect Dev Ctries; 2019 Oct; 13(10):877-885. PubMed ID: 32084017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Kidney Injury Related to Intravenous Colistin Use in Lebanese Hospitalized Patients: Incidence and Associated Factors.
    Khalifeh M; El-Lakany A; Soubra L
    Curr Drug Saf; 2022; 17(2):152-157. PubMed ID: 34323193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.
    Miano TA; Lautenbach E; Wilson FP; Guo W; Borovskiy Y; Hennessy S
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):542-550. PubMed ID: 29545383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.
    Rocco M; Montini L; Alessandri E; Venditti M; Laderchi A; De Pascale G; Raponi G; Vitale M; Pietropaoli P; Antonelli M
    Crit Care; 2013 Aug; 17(4):R174. PubMed ID: 23945197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin-induced Nephrotoxicity in a Tertiary Teaching Hospital.
    Al-Abdulkarim DA; Alzuwayed OA; Al Ammari M; Al Halwan S; Al Maklafi N; Thomas A
    Saudi J Kidney Dis Transpl; 2020; 31(5):1057-1061. PubMed ID: 33229769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral colistin for the treatment of severe infections: a single center experience.
    Tanita MT; Carrilho CM; Garcia JP; Festti J; Cardoso LT; Grion CM
    Rev Bras Ter Intensiva; 2013; 25(4):297-305. PubMed ID: 24553511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
    Rigatto MH; Oliveira MS; Perdigão-Neto LV; Levin AS; Carrilho CM; Tanita MT; Tuon FF; Cardoso DE; Lopes NT; Falci DR; Zavascki AP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2443-9. PubMed ID: 26856846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance.
    Aitullina A; Krūmiņa A; Svirskis Š; Purviņa S
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30709064
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria.
    Shields RK; Anand R; Clarke LG; Paronish JA; Weirich M; Perone H; Kieserman J; Freedy H; Andrzejewski C; Bonilla H
    PLoS One; 2017; 12(3):e0173286. PubMed ID: 28267779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin.
    Ballı FN; Ekinci PB; Kurtaran M; Kara E; Dizman GT; Sönmezer MÇ; Hayran M; Demirkan K; Metan G
    Int J Antimicrob Agents; 2024 Feb; 63(2):107035. PubMed ID: 37979889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia.
    Omrani AS; Alfahad WA; Shoukri MM; Baadani AM; Aldalbahi S; Almitwazi AA; Albarrak AM
    Ann Clin Microbiol Antimicrob; 2015 Jan; 14():3. PubMed ID: 25591721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.